Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

FAM-TRASTUZUMAB DERUXTECAN-NXKI

FDA · BLA · 2026-05-15

AgencyFDA
Submission typeBLA
Action date2026-05-15
BrandENHERTU
SponsorDAIICHI SANKYO
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:31:17.222Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:FAM-TRASTUZUMAB DERUXTECAN-NXKI:2026-05-15

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

FAM-TRASTUZUMAB DERUXTECAN-NXKI — approval | AEaH